Ackman's Pershing records big loss on slide of Valeant shares; Chinese pharma plans huge IPO;

@FiercePharma: Roche resolves patent war with India's Glenmark over generic Tarceva. More | Follow @FiercePharma

@EricPFierce: 18 months after the #FDA slapped Cadila with a Form 483, it sends a warning letter. News | Follow @EricPFierce

@CarlyHFierce: ICYMI: Shire could nab Baxalta for $32B this week: Bloomberg. Story | Follow @CarlyHFierce

> Sources say that China's Jiangsu Hansoh Pharmaceutical is planning a Hong Kong IPO that could raise up to $3 billion. Story

> Pershing Square Holdings, one of the funds overseen by investor Bill Ackman, ended the year down 20.5% after its investment in Valeant Pharmaceuticals ($VRX) contracted significantly last year. Story

> A new study has found that shortages of emergency room drugs, many lifesaving, quadrupled in the U.S. between 2001 and 2014. Story

Medical Device News

@FierceMedDev: NIH backs smartphone-based artificial pancreas trials with almost $13M. More | Follow @FierceMedDev

@EmilyWFierce: Pathway Genomics scores $40M in Series E round for genetic test development. Story | Follow @EmilyWFierce

@VarunSaxena2: ICYMI: Scottish researchers develop ingestible 'pill camera' that images non-visible light to detect cancer. More | Follow @VarunSaxena2

> FDA cracks down on transvaginal mesh devices amid safety concerns. More

> Pathway Genomics scores $40M in Series E round for genetic test development. Article

Biotech News

@FierceBiotech: The scoop on every new drug approved in 2015. Feature | Follow @FierceBiotech

@JohnCFierce: Annapurna adds three new gene therapy programs from Ron Crystal's lab at Weill Cornell. Story | Follow @JohnCFierce

@DamianFierce: I cannot prove that OncoCyte got its name from this generator, but I will take credit anyway. Website | Follow @DamianFierce

> Report: Chinese biopharma Jiangsu Hansoh eyes a $3B IPO. Story

> Gilead lines up for a fast FDA OK with its next-gen hep C combo. More

Pharma Manufacturing News

> Cadila to buy Zoetis animal drugs and feed plant in India for $29M. Item

> FDA slaps two Cadila facilities with warning letters. More

> Orchid gets favorable report for its formulation facility near Chennai. Story

> Reuters: J&J shopping its Noramco API unit for up to $800M deal. News

> FDA unveils new pharma manufacturing program as part of draft guidance. More

Drug Delivery News

> Clearside announces positive Phase II results in win for back-of-the-eye drug delivery. Story

> Halozyme picks up $150M credit deal on its Roche, Baxalta royalties. More

> Amgen partners with Unilife on wearable injectors, may buy 20% stake in the struggling company. Article

> UCSB team makes toxic transdermal drugs safer with salt formulation. News

> FDA approves nonalcoholic formulation of cancer drug, eliminating risk of intoxication following treatment. More

Pharma Asia News

> Japan's push on innovative drugs gets a budget boost. More

> India's hep C market sets a global pace on cost, access. Report

> Indonesia pharma investment cap eyed as top firms plan new plants. Story

> Sinovac gets China FDA new drug, production nod for HFMD vaccine. Article

> EU and India set Jan. 18 date for talks on GVK drug ban. Item

Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.